Cited by CrossRef (23)
- Cheol Ho Heo, Seon Young Bak, Yonghan Kim, Myoung-Ryul Ok, So Yeon Kim. Development of an integrin αv-based universal marker, capable of both prediction and direction of stem cell fate. Acta Biomaterialia 2023;166:291

- Hyun Seung Kim, Subin Jang, Jaemin Kim. Genome-Wide Integrative Transcriptional Profiling Identifies Age-Associated Signatures in Dogs. Genes 2023;14:1131

- Holly Lee, Peter Duggan, Ahsan Chaudhry, Paola Neri, Jason Tay, Fariborz Rashid-Kolvear, Nizar J. Bahlis, Victor H. Jimenez-Zepeda. Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center Experience. Clinical Lymphoma Myeloma and Leukemia 2018;18:e69

- Tomalika Rahmat Ullah. The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond. Journal of Bone Oncology 2019;17:100253

- Elisa Cocco, Manuela Leo, Claudia Canzonetta, Serena Di Vito, Antonello Mai, Dante Rotili, Arianna Di Napoli, Andrea Vecchione, Cosimo De Nunzio, Patrizia Filetici, Antonella Stoppacciaro. KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2. Clin Epigenet 2018;10

- Miao Li, Lin Qi, Jing-Bo Xu, Li-Ye Zhong, Szehoi Chan, Shu-Na Chen, Xin-Rong Shao, Li-Yuan Zheng, Zhao-Xia Dong, Tian-Liang Fang, Zhi-Ying Mai, Juan Li, Yongjiang Zheng, Xing-Ding Zhang. Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma. Molecular Therapy - Oncolytics 2020;19:197

- Thomas R. Cox, Janine T. Erler, Robin M. H. Rumney. Established Models and New Paradigms for Hypoxia-Driven Cancer-Associated Bone Disease. Calcif Tissue Int 2018;102:163

- Rofaida Gaballa, Hamdy E. A. Ali, Mohamed O. Mahmoud, Johng S. Rhim, Hamed I. Ali, Heba F. Salem, Mohammad Saleem, Mohamed A. Kandeil, Stefan Ambs, Zakaria Y. Abd Elmageed. Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition. Cancers 2020;12:2300

- Xiaoli Qian, Yang Yang, Yingfen Deng, Yali Liu, Yuwen Zhou, Fang Han, Yue Xu, Hongjian Yuan. SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation. Exp Ther Med 2023;25

- Alday-Parejo, Stupp, Rüegg. Are Integrins Still Practicable Targets for Anti-Cancer Therapy?. Cancers 2019;11:978

- Jun-Fu Wang, Ye Wang, Si-Wen Zhang, Ye-Yang Chen, Yue Qiu, Shao-Yi Duan, Bo-Pei Li, Jun-Qiang Chen, Nihal Ahmad. Expression and Prognostic Analysis of Integrins in Gastric Cancer. Journal of Oncology 2020;2020:1

- Seungjun Ahn, Tyler Grimes, Somnath Datta. The Analysis of Gene Expression Data Incorporating Tumor Purity Information. Front. Genet. 2021;12

- Anastazja Poczta, Aneta Rogalska, Agnieszka Marczak. Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches. JCM 2021;10:1841

- Shu‐Na Chen, Zhi‐Ying Mai, Jun‐Na Mai, Weiyao Liang, Zhao‐Xia Dong, Fei‐er Ju, Sze‐Hoi Chan, Zhigang Fang, Yichuan Xu, Orit Uziel, Chengwei He, Xing‐Ding Zhang, Yongjiang Zheng. E2F2 modulates cell adhesion through the transcriptional regulation of PECAM1 in multiple myeloma. Br J Haematol 2023;202:840

- Shusen Zhang, Dengxiang Liu, Xuecong Ning, Xiaochong Zhang, Yuanyuan Lu, Yang Zhang, Aimin Li, Zhiguo Gao, Zhihua Wang, Xiaoling Zhao, Shubo Chen , Zhigang Cai.
A Signature Constructed Based on the Integrin Family Predicts Prognosis and Correlates with the Tumor Microenvironment of Patients with Lung Adenocarcinoma
. J Environ Pathol Toxicol Oncol 2023;42:59

- Xuanguang Li, Guangsheng Zhu, Yongwen Li, Hua Huang, Chen Chen, Di Wu, Peijun Cao, Ruifeng Shi, Lianchun Su, Ruihao Zhang, Hongyu Liu, Jun Chen. LINC01798/miR-17-5p axis regulates ITGA8 and causes changes in tumor microenvironment and stemness in lung adenocarcinoma. Front. Immunol. 2023;14

- Xiulong Ma, Liang Zhang, Ling Liu, Dongli Ruan, Chunyang Wang. Hypermethylated ITGA8 Facilitate Bladder Cancer Cell Proliferation and Metastasis. Appl Biochem Biotechnol 2023

- Taro Ayabe, Masaharu Hisasue, Yoko Yamada, Suguru Nitta, Kaoruko Kikuchi, Sakurako Neo, Yuki Matsumoto, Ryo Horie, Kosuke Kawamoto. Characterisation of canine CD34+/CD45 diminished cells by colony-forming unit assay and transcriptome analysis. Front. Vet. Sci. 2022;9

- Yu Huang, Dong-Ming Guo, Shi Bu, Wei Xu, Qing-Chun Cai, Jian Xu, Yue-Quan Jiang, Fei Teng. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers. Adv Ther 2023;40:2186

- Yun Zhao, Xiaoxia Peng, Hope Baldwin, Chao Zhang, Zhongmin Liu, Xin Lu. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021;1867:166151

- Anna V. Komina, Nadezhda V. Palkina, Mariya B. Aksenenko, Semyon N. Lavrentev, Anton V. Moshev, Andrey A. Savchenko, Anton S. Averchuk, Yuri A. Rybnikov, Tatiana G. Ruksha. Semaphorin-5A downregulation is associated with enhanced migration and invasion of BRAF-positive melanoma cells under vemurafenib treatment in melanomas with heterogeneous BRAF status. 2019;29:544

- Eva Bianconi, Raffaella Casadei, Flavia Frabetti, Carlo Ventura, Federica Facchin, Silvia Canaider. Sex-Specific Transcriptome Differences in Human Adipose Mesenchymal Stem Cells. Genes 2020;11:909

- AmalA Elsharif, LaurenceH Patterson, StevenD Shnyder, HelenM Sheldrake. The role of integrins in acute leukemias and potential as targets for therapy. Tumor Microenviron 2018;1:63
